Analysts Set Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Target Price at $12.75
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) has earned a consensus recommendation of “Hold” from the seven brokerages that are currently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among […]
More Stories
Caledonia Mining (LON:CMCL) Shares Cross Below 200-Day Moving Average – Here’s What Happened
Caledonia Mining Co. Plc (LON:CMCL – Get Free Report) shares passed below its 200-day moving average during trading on Thursday...
Pacific Health Care Organization (OTCMKTS:PFHO) Stock Price Passes Below 200 Day Moving Average – What’s Next?
Pacific Health Care Organization, Inc. (OTCMKTS:PFHO – Get Free Report)’s stock price crossed below its two hundred day moving average...
Panther Metals (LON:PALM) Stock Price Crosses Below Two Hundred Day Moving Average – What’s Next?
Panther Metals PLC (LON:PALM – Get Free Report) crossed below its two hundred day moving average during trading on Thursday...
MYCELX Technologies (LON:MYX) Stock Crosses Below Two Hundred Day Moving Average – Should You Sell?
Shares of MYCELX Technologies Co. (LON:MYX – Get Free Report) crossed below its two hundred day moving average during trading...
Trimedyne (OTCMKTS:TMED) Stock Price Crosses Below 200-Day Moving Average – Here’s What Happened
Shares of Trimedyne, Inc. (OTCMKTS:TMED – Get Free Report) crossed below its 200-day moving average during trading on Thursday ....
Cannabis Sativa (OTCMKTS:CBDS) Share Price Passes Above 50 Day Moving Average – Time to Sell?
Cannabis Sativa, Inc. (OTCMKTS:CBDS – Get Free Report) shares crossed above its 50-day moving average during trading on Thursday ....